Justin Leong - 22 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President, Asia Latin America
Signature
Justin Leong, President Asia and Latin America
Issuer symbol
RMD
Transactions as of
22 Nov 2022
Net transactions value
-$420
Form type
4
Filing time
23 Nov 2022, 15:42:19 UTC
Previous filing
18 Nov 2022
Next filing
06 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ReMed Common Stock Options Exercise $866,400 +15,000 +31% $57.76 63,594 22 Nov 2022 Direct
transaction RMD ReMed Common Stock Sale $866,820 -3,777 -5.9% $229.50 59,817 22 Nov 2022 Direct F1
transaction RMD ReMed Common Stock Award $0 +6,924 +12% $0.000000 66,741 23 Nov 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -15,000 -100% $0.000000* 0 22 Nov 2022 ResMed Common Stock 15,000 $57.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price.
F2 Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.